Ozempic and Mounjaro are FDA approved for type 2 diabetes, so eligibility for those medications is determined by a licensed provider during intake
Trial averages describe a group, not a person, and your doctor is best positioned to weigh how a medications mechanism, side effect profile, and delivery method fit your specific situation
Associations of semaglutide with Alzheimers disease-related dementias in patients with type 2 diabetes: a real-world target trial emulation study
Nevertheless, further research is needed to assess the medications safety in populations with major depressive disorder, schizophrenia, or a history of suicide attempts
Yin HY, Tighe S, Tseng SC, Cheng AM